Trevor Hallam, Chief Scientific Officer at SUTRO BIOPHARMA, INC. (STRO), sold 16,751 shares at $15.00 ($251K) on 2020-11-05, disclosed to the SEC on 2020-11-06.
Open-market sale of $251k STRO by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| STRO | SELL | 2020-11-30 | $41K | — | Filing → |
| STRO | SELL | 2020-09-28 | $10K | — | Filing → |
| STRO | SELL | 2020-08-27 | $9K | — | Filing → |